Stem Cell Reviews and Reports

, Volume 5, Issue 4, pp 315–318

The Practical Consequences of a National Human Embryonic Stem Cell Registry


DOI: 10.1007/s12015-009-9091-z

Cite this article as:
Taymor, K. & Scott, C.T. Stem Cell Rev and Rep (2009) 5: 315. doi:10.1007/s12015-009-9091-z


The executive order and issuance of federal guidelines for human embryonic stem cell research are positive developments and will produce long-term benefits by creating a new registry for hESC lines. But there may be short-term costs caused by regulatory uncertainty, procedural delay, and knock-on effects as national policies are adopted at state and local jurisdictions. Policymakers must ensure that national mechanisms of oversight for a new hESC registry are adequately funded, properly organized, transparent, and free of bureaucratic detail.


Embryonic stem cells Embryonic stem cell lines Biomedical ethics Bioethics Policy NIH Guidelines for Embryonic Stem Cell Research Informed consent Barack Obama Executive order Federal Advisory Committee Act (FACA) National Stem Cell Bank Stem cell registry Embryonic stem cell research oversight (ESCRO) Institutional review board (IRB) 

Copyright information

© Springer Science + Business Media 2009

Authors and Affiliations

  1. 1.Berkeley Center for Law, Business and the EconomyUniversity of CaliforniaBerkeleyUSA
  2. 2.Program on Stem Cells in Society, Center for Biomedical EthicsStanford UniversityStanfordUSA

Personalised recommendations